| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100768 | Journal of Crohn's and Colitis | 2009 | 6 Pages |
Abstract
Infliximab therapy is effective for maintenance of clinical remission and mucosal healing in patients with steroid-dependent UC.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Manuel Barreiro-de Acosta, Aurelio Lorenzo, Jose Mera, J. Enrique Dominguez-Muñoz,